Project Details
Short title | A multicentre, open label, phase I/ randomised Phase II study to evaluate safety, pharmacokinetics, and efficacy of BIBF 1120 in comparison with oral sorafenib for advanced hepatocellular carcinoma patients. |
---|---|
Status | Active |
Effective start/end date | 28/10/09 → 31/12/24 |
Funding
- Uhb Nhs Trust